IPO Boutique

Spring Bank Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Spring Bank Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Spring Bank PharmaceuticalsSBPH -
NASDAQ
$12.00-$14.00 $12.00 $11.280.92 million5/6/2016
Dawson James Securities
Co-Manager(s):
Health Care
Filing(s):

1st Filed 2016-01-05
Terms Added 2016-03-09
Filed 2016-04-27



Spring Bank Pharmaceuticals Quote & Chart - Click for current quote - SBPH

About Spring Bank Pharmaceuticals (adapted from Spring Bank Pharmaceuticals prospectus):
They are a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using our proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "SBPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved